Gates Medical Research Institute

This early-stage trial tested a lab-made antibody called MAM01 in 63 healthy adults who had never had malaria. The goal was to see if it is safe and can prevent malaria infection when people are deliberately exposed to the parasite. The study is complete, but results are not yet …

This study tested a new drug called MAM01 to see if it is safe and could help prevent malaria for at least 4 months. It involved 125 healthy adults and children living in parts of Africa where malaria is common. Researchers gave different doses of MAM01 or a placebo and monitored…

This study tested a new drug called MK-7762 in 119 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo in single or multiple doses. The goal was to check for side effects and measure drug levels in the blood, not t…

This early-stage trial tested the safety and tolerability of a new drug called TBD11 in 124 healthy adults. Participants received either single or multiple doses of TBD11 or a placebo, and some took it with food to see if that changed how the drug behaves. The study is complete a…

This early-phase trial tested the safety and tolerability of a new drug called TBD09 in 36 healthy adults. Participants took either TBD09 or a placebo daily for 84 days. The goal was to check for side effects and how the drug moves through the body, not to treat any disease.